Evofem’s PHEXX® Receives Pricing Certificates in UAE, Paving Way for Launch Evofem Biosciences announces the issuance of favorable pricing certificates for PHEXX® in the UAE, a crucial step towards its 2026 commercial launch.

Evofem’s PHEXX® Receives Pricing Certificates in UAE, Paving Way for Launch #Dubai #UAE #Pharma_1 #Evofem #PHEXX

Evofem's SOLOSEC Approved for Launch in the UAE for Women's Health Evofem's innovative treatment, SOLOSEC®, targets bacterial vaginosis and trichomoniasis, aiming for a 2026 launch in the UAE. Discover more about this significant advancement in women's health.

Evofem's SOLOSEC Approved for Launch in the UAE for Women's Health #Abu_Dhabi #United_Arab_Emirates #SOLOSEC #Pharma_1 #Evofem

Evofem's 'Say Vagina' Campaign Achieves Over 2.5 Million Views in August Evofem Biosciences' innovative 'Say Vagina' campaign significantly raises awareness, generating over 2.5 million views and increasing engagement for its contraceptive brand PHEXXI.

Evofem's 'Say Vagina' Campaign Achieves Over 2.5 Million Views in August #PHEXXI #Evofem #Say_Vagina

Evofem Biosciences Celebrates CEO Saundra Pelletier's Award at STIMULATE Conference Saundra Pelletier, CEO of Evofem Biosciences, receives the prestigious Trailblazing Female Founders Award at the STIMULATE Conference, celebrating female leadership.

Evofem Biosciences Celebrates CEO Saundra Pelletier's Award at STIMULATE Conference #United_States #Nashville #Evofem #Saundra_Pelletier #STIMULATE